99115-96-5

Basic information

• Product Name: 2-Pentanone, 3-(hydroxymethyl)- (6CI,9CI)
• Synonyms: 2-Pentanone, 3-(hydroxymethyl)- (6CI,9CI)
• CAS NO: 99115-96-5
• Molecular Formula: C₆H₁₂O₂
• Molecular Weight: 116.15828
• Product Categories: ACETYLGROUP
• Mol File: 99115-96-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Pentanone, 3-(hydroxymethyl)- (6CI,9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pentanone, 3-(hydroxymethyl)- (6CI,9CI)(99115-96-5)
• EPA Substance Registry System: 2-Pentanone, 3-(hydroxymethyl)- (6CI,9CI)(99115-96-5)

Safety Data

• Hazardous Substances Data: 99115-96-5(Hazardous Substances Data)

Upstream product

• 210359-35-6 2-(2-methyl-1,3-dioxolan-2-yl)butan-1-ol 
• 50-00-0 formaldehyd 
• 107-87-9 2-Pentanone 
• 51756-08-2 methyl 2-ethyl-3-oxobutanoate 
• 607-97-6 ethyl 2-ethyl-3-oxobutanoate 
• 27773-10-0 carbethoxy-1 ethylene dioxy-2 ethyl-1 propane 

Downstream Products

• 174418-82-7 Mitragynine hydroxyindolenine 
• 6202-22-8 methyl (Z)-2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate 
• 4098-40-2 mitragynine 
• 6202-22-8 (+)-mitragynine 
• 103358-95-8 5-ethyl-6-methyl-hept-5-en-2-one 
• 210359-44-7 benzyl 9-(5-benzyloxycarbonyl-4-ethyl-3-methyl-2-pyrrolyl)-3-methylcycloocta[b]pyrrole-2-carboxylate 
• 210359-43-6 benzyl 8-(5-benzyloxycarbonyl-4-ethyl-3-methyl-2-pyrrolyl)-3-methylcyclohepta[b]pyrrole-2-carboxylate 
• 51089-83-9 benzyl 4-ethyl-3-methyl-1H-pyrrole-2-carboxylate 
• 4359-77-7 3-ethyl-3-buten-2-one 

Relevant articles and documents

MITRAGYNINE ALKALOIDS AS OPIOID RECEPTOR MODULATORS

The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof, and a method of treating a subject afflicted with pain, a depressive disorder, a mood disorder or an anxiety disorder by administering the compound to the subject.

SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS

This invention concerns sulfonylpyrazoline carboxamidine derivatives as antagonists of 5-HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes. The compounds have the general formula (1), wherein the symbols have the meanings given in the description.